4. Formas clínicas del síndrome coronario agudo (SCA):

4.1 Angina de pecho inestable ____
4.2 Infarto agudo de miocardio (IAM) ____

5. Tratamiento médico empleado:

5.1 Antiagregantes plaquetarios ____
5.2 Nitritos ____
5.3 IECA ____
5.4 Trombolíticos ____
5.5 Betabloqueadores ____
5.6 Anticoagulantes ____
5.7 Antiarrítmicos ____
5.8 Aminas vasopresoras ____

6. Complicaciones:

6.1 Edema pulmonar ____
6.2 Shock cardiogénico ____
6.3 Complejos ventriculares prematuros ____
6.4 Taquicardia supraventricular paroxística ____
6.5 Taquicardia ventricular ____
6.6 Fibrilación ventricular ____
6.7 Bloqueo aurículo-ventricular (AV) de II y III grado ____
6.8 Embolismo cerebral ____
6.8 Fibrilación auricular ____

7. Estado al egreso:

7.1 Vivo ____
7.2 Fallecido ____


REFERENCIAS BIBLIOGRÁFICAS:

1- Rozman Farreras C. Tratado de Medicina Interna. España 2000; Cap 66, 67.
2- Hernández F, Sanz García RM, Sánchez V. Manual de Medicina Interna 12 de Octubre. Cardiología 1998; Cap 2.
3- Roca Goderich R. Temas de Medicina Interna. La Habana. Edit Ciencias Médicas; 2002. 1. p. 392- 418.
4- Cecil. Tratado de Medicina Interna. 20ª Edición. Vol.1. Cap. 31 Editorial Ciencias Medicas. La Habana. 1988. páginas 198-02, 209.
5- Silver SH, Leo PJ, Katapadi M. Serial electro cardiagrams for chest pain in pacients with initial no diagnostic electrocardiograms: implications for thrombolytic therapy. Acad Emerg Med 1996; 3 (2):
6- Colucci WS. Heart Failure: Cardiac Function and Dysfunction. En: Braunwald E, ed. Atlas of heart diseases, vol. 4. Filadelfia, Current Medicine, 1995.
7- Katz AM. Physiology of the heart. Nueva York, Raven Press, 1992.
8- Perloff JK. Physical Examination of the Heart and Circulation. Filadelfia, Saunders, 1990.
9- Schlant R. Chairman of Committee of Electrocardiography of Task force ACC/AHA. Guidelines for electrocardiography. Circulation 1991; 85:1221.
10- Navarro F. Análisis de la función diastólica del ventrículo izquierdo: relajación y distensibilidad. En: Iriarte MM, Sagastagoitia JD, eds. Insuficiencia cardíaca crónica. Barcelona, MCR, 1989; 137-162.
11- Opie LH. Mechanisms of cardiac contraction and relaxation. En: Braunwald E, ed. Heart Disease, 5.ª ed. Filadelfia, Saunders 1997; 360-393.
12- Young JB, Haas GJ, Starling RC. Insufficiencies cardíaca. En: ACCSAP. Adult Clinical Cardiology Self-Assessment Program. American College of Cardiology (ed. esp.). Barcelona, Medical Trends, 1998
13- Selwyn AP, Kinlay S, Creager M, Libby P, Ganz P. Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease. American Journal of Cardiology, 1997; 79: 17- 23.
14- Fuster V, Ross R, Topol E, editors. Atherosclerosis and coronary artery disease. Filadelfia: Lippincott- Roven, 1996; 1097-1124.
15- Futterman LG, Lemberg L. Endothelium: the key to medical management of coronary artery disease. American Journal of Cardiology, 1997; 6: 159-167.
16- Abrams J. Role of endothelial dysfunction in coronary artery disease. American Journal of Cardiology, 1997; 79: 2- 9.
17- Kuller I, Borbani N, Funberg C, Gardin J. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol, 1994; 139: 1164- 1179
18- Poch E, Jiménez W, Feu F, Coca A, Boteu A, Bosch J, Rivera F, Revert L. Increased plasma endothelin concentration in atherosclerotic renovascular hypertension. Nephron 1995; 71: 291-296.
19- Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and acute coronary syndroms. N Engl J Med 1992; 326: 242- 250.
20- Constant J. Bedside Cardiology. 4.ª ed. Boston, Little Brown, 1993.
21- Giuliani ER, Gersh BJ, McGoon MD. Mayo Clinic Practice of Cardiology. 3.ª ed. Filadelfia, Mosby 1996.
22- Uretsky BF, Runge MS. Angina Unstable/ Diagnosis/ Therapy. Cardiology Clinic, 1999, May: 17 (2): XIII- XVII.
23- Masia R, Pera A, Marrugat J, Sola J, Vila J, Paresi M et al and the REGICOR investigators. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. J Epidemiol Commun Health 1998; 52: 707-715.
24- Álvarez Sintes R. Temas de Medicina General Integral. La Habana. Editorial Ciencias Médicas, 2001. Cap 19. p. 536- 556
25- Stamler J, Samler R, Neaton JD. Blood pressure systolic and diastolic, and cardiovascular risk: US population Data. Arch Intern Med 1993; 153: 598-615.
26- Sheped J, Cobre SM, Ford I et al. Prevention of coronary heart disease with prevention men with hypercholesterolemia. New Eng J Med, 1995; 333: 1301.
27- Garber AM, Browner WS. Cholesterol screening guidelines. Consensus, evidence and common sense. Circulation 1997; 95: 1642- 1645
28- Hoffner SM, Miettinen H. Insulin resistance implications for type II Diabetes Mellitus and coronary heart disease. American Journal of Medicine, 1997; 103: 152- 162.
29- Grundy SM. Cholesterol and Obesity in coronary heart disease. The 21st century. Archives of Internal Medicine, 1997; 157: 1177- 1184.
30- Stewart RA, North FM, West TM et al. Depression and cardiovascular morbidity and mortality: cause or consequence.Eur Heart J. 2003 Nov; 24 (22):2027.
31- Médica Panamericana; 1991.p.555...Eagle Kim A, Haber E, De Sacntis R.W, Austin W.G. La práctica de la Cardiología. Normas del Massachussets General Hospital. 2ª ed. Buenos Aires
32- Braunwald E. Heart Disease. 5.ª ed. Filadelfia, Saunders, 1997
33- Grundy SC, Balady G, Criqui M, Fletcher G, Greenland P, Hinatzka L et al. When to start cholesterol- lowening therapy in patients when coronary heart disease. A statement for health care professionals from the American Heart Association Task Force on risk reduction. Circulation 1997; 95: 1683- 1685
34- Cruickshank JM. Clinical importance of coronary perfusion pressure in the hypertensive patient with left ventricular hypertrophy. Cardiology 1992; 81:283-290
35- Zaaks SM, Liebson PR, Calvin JE. Unstable angina and non Q wave myocardial infarction: Does the clinical diagnosis have therapeutic implications? J. Am Coll Cardiol 1999:33.
36- Hernández Padial L. Usefulness of total 12-lead QRS voltage for determining the presence of left ventricular hypertrophy in systemic hypertension. Am J Cardiol 1991; 68:261-262.
37- Galve E, Ordi J, Candell J, Soler Soler J. Enfermedades del tejido conectivo y corazón. Rev Esp Cardiol 1998; 51:232-242.
38- Bayés de Luna A, Cladellas M, Oter R, Torner P, Guindo J, Martí V et al. Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmias. Eur Heart J 1988; 9:1112.
39-. Braunwald E. Heart Disease. A text of cardiovascular medicine. philadelphia: WB Saunders; 1998.
40- Braunwald E. Unstable angina: A classification. Circulation 1999; 80: 410- 414.
41-Canadian Cardiovascular Society. A classification of Unstable angina. Circulation 1998; 40: 325-336.
42-. Kunstman S, Corbalen R, Castro P, Rodríguez JA. Características clínicas y seguimiento de la angina inestable: Factores pronósticos de mortalidad. Rev Chilena Cardiol 2000; 12 (2): 72-77